Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Silk Road Medical Q4 2023 GAAP EPS $(0.33) Beats $(0.42) Estimate, Sales $47.27M Beat $41.97M Estimate

Author: Benzinga Newsdesk | February 28, 2024 05:15pm
Silk Road Medical (NASDAQ:SILK) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.42) by 21.43 percent. The company reported quarterly sales of $47.27 million which beat the analyst consensus estimate of $41.97 million by 12.62 percent. This is a 17.97 percent increase over sales of $40.07 million the same period last year.

Posted In: SILK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist